Literature DB >> 33092421

COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma.

M Arenbergerova1, S Gkalpakiotis1, P Arenberger1, A Fialova1, M Pasek1.   

Abstract

Entities:  

Year:  2020        PMID: 33092421     DOI: 10.1080/09546634.2020.1822500

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


× No keyword cloud information.
  1 in total

1.  Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.

Authors:  C Trojaniello; M G Vitale; P A Ascierto
Journal:  Ann Oncol       Date:  2021-02-16       Impact factor: 32.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.